Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
Dirk Schürmann, Sonja V. Sorensen, Erwin De Cock, Sandeep Duttagupta and Ansgar Resch:
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
The European Journal of Health Economics, Volume 10, Number 1 / Februar 2009, Springer Berlin / Heidelberg
[DOI:10.1007/s10198-008-0104-7]
Write a comment
You must be logged in to post a comment.

del.icio.us